Potassium clorazepate (Tranxene)-induced jaundice

Abstract

A first report of jaundice and hepatic necrosis probably due to potassium clorazepate is described. The histology is discussed and it is suggested that the drug should not be given in the presence of suspected hepatic dysfunction.

Full text

PDF

• 908
• 909
• 910
• Next

Images in this article

Fig. 1
on p.908

Fig. 2
on p.909

Fig. 3
on p.910